NKG2D CAR-NK

CAR-NK cell therapy targeting NKG2D ligands

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKG2D CAR-NK, covering 2025-03-04 to 2025-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATC [Phase 1, Phase 2]